Powered by

Zydus completes phase 2 clinical trial in Covid patients with bio-therapy

Nov 12, 2020 - Business Standard India

Zydus Cadila said it has successfully completed a phase 2 clinical trial In Covid-19 patients with its biological therapy, 'PegiHep', and it will now begin phase 3 clinical trial. Drug firm Zydus Cadila on Thursday said

it has successfully completed a phase 2 clinical trial In COVID-19 patients with its biological therapy, 'PegiHep', and it will now begin phase 3 clinical trial. In a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COV...